J.-J. Feldtrauer

856 total citations
19 papers, 720 citations indexed

About

J.-J. Feldtrauer is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, J.-J. Feldtrauer has authored 19 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in J.-J. Feldtrauer's work include Neuroscience and Neuropharmacology Research (12 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Pain Mechanisms and Treatments (3 papers). J.-J. Feldtrauer is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Pain Mechanisms and Treatments (3 papers). J.-J. Feldtrauer collaborates with scholars based in Switzerland and United States. J.-J. Feldtrauer's co-authors include P. C. Waldmeier, Peter Wicki, John J. Lemasters, Ting Qian, P. A. Baumann, Peter Baumann, H. Bittiger, Markus Schmutz, Stuart J. Mickel and Peter Baumann and has published in prestigious journals such as Neurology, Biological Psychiatry and British Journal of Pharmacology.

In The Last Decade

J.-J. Feldtrauer

18 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-J. Feldtrauer Switzerland 13 389 379 105 77 67 19 720
Yana Adamchik Canada 10 286 0.7× 328 0.9× 86 0.8× 48 0.6× 91 1.4× 10 620
Jean Rataud France 11 295 0.8× 400 1.1× 55 0.5× 27 0.4× 58 0.9× 19 618
Siesjø Bk Sweden 10 271 0.7× 227 0.6× 45 0.4× 59 0.8× 118 1.8× 14 685
Roi Ann Wallis United States 15 257 0.7× 250 0.7× 79 0.8× 49 0.6× 204 3.0× 22 714
Chi Zhao-fu China 20 442 1.1× 274 0.7× 115 1.1× 44 0.6× 199 3.0× 45 951
Kimberly L. Panizzon United States 13 278 0.7× 307 0.8× 83 0.8× 43 0.6× 208 3.1× 19 747
Amiram I. Barkai United States 12 141 0.4× 166 0.4× 89 0.8× 31 0.4× 68 1.0× 34 447
Toshikiyo Shohmori Japan 16 261 0.7× 136 0.4× 42 0.4× 27 0.4× 81 1.2× 41 578
Cynthia H. Donnelly United States 9 220 0.6× 286 0.8× 184 1.8× 45 0.6× 71 1.1× 11 724
Jyrki Rintala Finland 10 173 0.4× 188 0.5× 151 1.4× 56 0.7× 63 0.9× 12 568

Countries citing papers authored by J.-J. Feldtrauer

Since Specialization
Citations

This map shows the geographic impact of J.-J. Feldtrauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-J. Feldtrauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-J. Feldtrauer more than expected).

Fields of papers citing papers by J.-J. Feldtrauer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-J. Feldtrauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-J. Feldtrauer. The network helps show where J.-J. Feldtrauer may publish in the future.

Co-authorship network of co-authors of J.-J. Feldtrauer

This figure shows the co-authorship network connecting the top 25 collaborators of J.-J. Feldtrauer. A scholar is included among the top collaborators of J.-J. Feldtrauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-J. Feldtrauer. J.-J. Feldtrauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Waldmeier, P. C., Peter Wicki, J.-J. Feldtrauer, & Peter Baumann. (2004). Ca2+-dependent release of endogenous GABA from rat cortical slices from different pools by different stimulation conditions. Naunyn-Schmiedeberg s Archives of Pharmacology. 339-339(1-2). 200–207.
2.
Waldmeier, P. C., J.-J. Feldtrauer, Ting Qian, & John J. Lemasters. (2002). Inhibition of the Mitochondrial Permeability Transition by the Nonimmunosuppressive Cyclosporin Derivative NIM811. Molecular Pharmacology. 62(1). 22–29. 241 indexed citations
3.
Wicki, Peter, et al.. (1995). Effects of the putative P-type calcium channel blocker, R,R-(?)-daurisoline on neurotransmitter release. Naunyn-Schmiedeberg s Archives of Pharmacology. 352(6). 670–8. 8 indexed citations
4.
Waldmeier, P. C., et al.. (1995). Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology. 45(10). 1907–1913. 109 indexed citations
5.
Waldmeier, P. C., Peter Wicki, J.-J. Feldtrauer, et al.. (1994). GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors. British Journal of Pharmacology. 113(4). 1515–1521. 82 indexed citations
6.
Waldmeier, P. C., et al.. (1993). Serotonin uptake inhibition by the monoamine oxidase inhibitor brofaromine. Biological Psychiatry. 33(5). 373–379. 7 indexed citations
7.
Wicki, Peter, et al.. (1993). Release of endogenous glutamate from rat cortical slices in presence of the glutamate uptake inhibitor L-trans-pyrrolidine-2,4-dicarboxylic acid. Naunyn-Schmiedeberg s Archives of Pharmacology. 348(5). 478–85. 26 indexed citations
8.
Waldmeier, P. C., et al.. (1992). Weak effects of local and systemic administration of the GABA uptake inhibitor, SK&F 89976, on extracellular GABA in the rat striatum. Naunyn-Schmiedeberg s Archives of Pharmacology. 345(5). 544–7. 18 indexed citations
9.
Waldmeier, P. C., et al.. (1992). Systemic administration of baclofen and the GABAB antagonist, CGP 35348, does not affect GABA, glutamate or aspartate in microdialysates of the striatum of conscious rats. Naunyn-Schmiedeberg s Archives of Pharmacology. 345(5). 548–52. 13 indexed citations
10.
Waldmeier, P. C., P. A. Baumann, J.-J. Feldtrauer, et al.. (1990). CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(3). 305–311. 34 indexed citations
11.
Waldmeier, P. C., Peter Wicki, J.-J. Feldtrauer, & Peter Baumann. (1989). Release of endogenous GABA from the substantia nigra is not controlled by GABA autoreceptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(4). 372–378. 14 indexed citations
12.
Waldmeier, P. C., Peter Wicki, J.-J. Feldtrauer, & P. A. Baumann. (1988). The measurement of the release of endogenous GABA from rat brain slices by liquid chromatography with electrochemical detection. Naunyn-Schmiedeberg s Archives of Pharmacology. 337(3). 284–8. 21 indexed citations
13.
Wicki, Peter, et al.. (1988). Potential involvement of a baclofen-sensitive autoreceptor in the modulation of the release of endogenous GABA from rat brain slices in vitro. Naunyn-Schmiedeberg s Archives of Pharmacology. 337(3). 289–95. 77 indexed citations
14.
Waldmeier, P. C. & J.-J. Feldtrauer. (1987). On the role of O-methylation in the metabolism of S-adenosylmethionine in rat brain. Biochemical Pharmacology. 36(17). 2855–2861. 13 indexed citations
15.
Waldmeier, P. C., et al.. (1983). Reversibility of the interaction of CGP 11305 A with MAO A in vivo. European Journal of Pharmacology. 94(1-2). 101–108. 19 indexed citations
16.
Waldmeier, P. C., et al.. (1983). Urinary excretion of O-methylated catecholamines, tyramine and phenyl-ethylamine by volunteers treated with tranylcypromine and CGP 11305 A. European Journal of Clinical Pharmacology. 25(3). 361–368. 24 indexed citations
17.
Waldmeier, P. C., et al.. (1983). The effects of amfonelic acid on 5-HT metabolism in rat brain. Journal of Neural Transmission. 57(3). 149–165. 7 indexed citations
18.
Waldmeier, P. C., et al.. (1980). Effects of baclofen on striatal dopamine and serotonin metabolism. Brain Research Bulletin. 5. 545–548. 1 indexed citations
19.
Waldmeier, P. C., et al.. (1979). Effects of baclofen on striatal 5-HT mediated by the nigrostriatal dopamine system. European Journal of Pharmacology. 54(3). 279–287. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yana Adamchik Breakdown of academic impact, for papers by Jean Rataud Breakdown of academic impact, for papers by Siesjø Bk Breakdown of academic impact, for papers by Roi Ann Wallis Breakdown of academic impact, for papers by Chi Zhao-fu Breakdown of academic impact, for papers by Kimberly L. Panizzon Breakdown of academic impact, for papers by Amiram I. Barkai Breakdown of academic impact, for papers by Toshikiyo Shohmori Breakdown of academic impact, for papers by Cynthia H. Donnelly Breakdown of academic impact, for papers by Jyrki Rintala
Rankless by CCL
2026